PetIQ

PetIQ, Inc. is a holding company, which engages in the manufacture, procurement, packaging, and distribution of pet health and wellness products. It operates through the Products and Services segments. The Products segment produces and distributes pet medication and health and wellness products to the retail channel. The Services segment represents all veterinary services, and related product sales provided by the firm directly to consumers. Its brands include Advecta, Betsy Farms, Delightibles, Tex Ranch, Mimis Market, and PetLock. The company was founded by McCord Christensen in 2010 and is headquartered in Eagle, ID.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

PetIQ reports robust Q4 performance, eyes growth through acquisitions

PetIQ delivered a strong performance in Q4 2022, showcasing growth in sales, margins, and operational efficiency across its product and service segments.
While facing challenges from consumer trade-down and integration complexities, the company's strategic focus on brand portfolio expansion and service enhancements positions it for future success.
Opportunities lie in new product introductions, service expansions, and partnership growth, indicating a positive outlook for PetIQ's continued growth trajectory.
With a solid financial foundation, strategic acquisitions, and operational improvements, PetIQ is poised to capitalize on market opportunities and drive sustainable growth.

PetIQ reports record Q1 earnings, eyes growth in premium products

PetIQ delivered strong financial performance in Q1 2023, driven by robust sales growth and operational efficiency improvements.
While facing challenges in hiring veterinarians and transitioning production, the company is well-positioned for future growth.
Opportunities lie in expanding product offerings, optimizing operations, and leveraging e-commerce for sustained growth.
Overall, PetIQ remains optimistic about future performance and is on track to meet full-year expectations.

PetIQ reports record Q2 earnings, eyes growth through innovation

PetIQ delivered strong financial performance in Q2 2023, driven by robust sales growth and operational improvements across segments.
While facing challenges in managing product mix and operational efficiency, the company remains optimistic about future growth opportunities.
By focusing on customer-centric strategies, investing in innovation, and planning significant product launches, PetIQ is well-positioned for continued success.

PetIQ reports record Q3 earnings, eyes growth through operational efficiency

PetIQ's Q3 performance exceeded expectations, driven by strong sales growth in key product categories. The company's focus on operational efficiency and strategic decision-making bode well for future success. Despite challenges in certain segments, PetIQ's outlook remains positive with opportunities for continued growth and market differentiation.

PetIQ reports strong Q4 earnings, eyes growth amid market challenges

PetIQ's Q4 2023 earnings reflect robust financial performance, strategic growth initiatives, and a positive outlook for 2024, underpinned by strong brand growth and operational efficiency.
While facing challenges such as seasonal variability and market risks, PetIQ's focus on margin expansion, disciplined acquisitions, and market positioning present opportunities for sustained success and market leadership.
With a conservative approach, emphasis on pet health and wellness products, and a clear growth strategy, PetIQ is poised for continued momentum and execution in the pet care industry.

PetIQ reports record Q1 earnings, raises guidance for 2024

PetIQ's Q1 performance exceeded expectations, driven by strong sales and margin expansion. While facing challenges such as higher expenses, the company is poised for growth with raised guidance and planned marketing investments. Leveraging opportunities in key product categories and services segment expansion will be crucial for sustained success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

PetIQ specializes in affordable veterinary services and a wide range of pet health products. The company focuses on preventive care, ensuring pet owners have convenient access to necessary treatments and medications. With integrated manufacturing and distribution capabilities, PetIQ aims to enhance pet health and wellness.

EAGLE, Idaho and NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced the successful completion of its acquisition by Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, in an all-cash transaction valued at approximately $1.5 billion.

PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group

Reports Merger Agreement with Bansk Group Approved by Stockholders and Anticipates a Closing Date of October 25, 2024 Reports Merger Agreement with Bansk Group Approved by Stockholders and Anticipates a Closing Date of October 25, 2024

PetIQ, Inc. Announces Results of Special Meeting of Stockholders

First Bancshares

NEW YORK, NY / ACCESSWIRE / October 9, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating: PetIQ, Inc. (Nasdaq: PETQ ), relating to its proposed merger with Bansk Group.

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers and Upcoming Votes of PETQ and FBMS

NEW YORK, NY / ACCESSWIRE / October 8, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating: PetIQ, Inc. (NASDAQ: PETQ ), relating to its proposed merger with Bansk Group.

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers and Imminent Votes of PETQ and FBMS

NEW YORK, NY / ACCESSWIRE / October 7, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating: PetIQ, Inc. (Nasdaq: PETQ ), relating to its proposed merger with Bansk Group.

STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers and Imminent Votes of PETQ and FBMS

PetIQ (PETQ) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

PetIQ, Inc. (PETQ) Hits Fresh High: Is There Still Room to Run?

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, PetIQ (PETQ) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Fast-paced Momentum Stock PetIQ (PETQ) Is Still Trading at a Bargain

PetIQ (PETQ) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

PetIQ (PETQ) Upgraded to Strong Buy: What Does It Mean for the Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy PetIQ (PETQ) Stock?

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of PetIQ, Inc. (NASDAQ: PETQ) to Bansk Group for $31.00 per share in cash is fair to PetIQ shareholders. Halper Sadeh encourages PetIQ shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether PetIQ and its board of directo.

PETQ Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of PetIQ, Inc. Is Fair to Shareholders

NEW YORK , Aug. 9, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating PetIQ, Inc. (Nasdaq: PETQ ), relating to its proposed merger with Bansk Group.

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of PetIQ, Inc. - PETQ

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of PetIQ, Inc. (NasdaqGS: PETQ) to Bansk Group. Under the terms of the proposed transaction, shareholders of PetIQ will receive $31.00 in cash for each share of PetIQ that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration und.

PETIQ INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PetIQ, Inc. - PETQ

G1 Therapeutics

NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GTHX, PETQ on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / August 8, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating PetIQ, Inc. (Nasdaq: PETQ ), relating to its proposed merger with Bansk Group.

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of PetIQ, Inc. – PETQ

Dril-Quip

NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PETQ, DRQ on Behalf of Shareholders

MILWAUKEE, Aug. 7, 2024 /PRNewswire/ -- Ademi LLP is investigating PetIQ (Nasdaq: PETQ) for possible breaches of fiduciary duty and other violations of law in its transaction with Bansk. Click here to learn how to join our investigation https://www.ademilaw.com/case/petiq-inc or call Guri Ademi toll-free at 866-264-3995.

Shareholder Alert: Ademi LLP investigates whether PetIQ, Inc. has obtained a Fair Price for its Public Shareholders

Pet medications wholesaler PetIQ agreed to a $1.5 billion buyout Wednesday, sending shares into the stratosphere.

PetIQ Stock Rockets 48% To A Three-Year High On A $1.5 Billion Takeover

PetIQ (PETQ) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.46 per share a year ago.

PetIQ (PETQ) Tops Q2 Earnings Estimates

PetIQ Inc. PETQ, -0.63%, an Idaho-based pet wellness company, said Wednesday it's agreed to be acquired by investment firm Bansk Group for $31 a share in cash, or about $1.5 billion. The price is equal to a premium of about 41% over the 30-day volume-weighted average stock price as of Tuesday, and a premium of about 51% to the closing stock price on that day.

PetIQ agrees to be acquired by Bansk Group in all-cash deal valued at $1.5 billion

Private equity firm Bansk Group will acquire pet health company PetIQ for about $1.5 billion in cash, the companies said on Wednesday.

Bansk Group to buy PetIQ for $1.5 billion

Generates Record Second Quarter 2024 Net Sales and Net Income Record Adjusted EBITDA of $39.0 Million Exceeds Company's Second Quarter 2024 Guidance PetIQ and Bansk Group Sign Definitive Merger Agreement

PetIQ, Inc. Reports Second Quarter 2024 Financial Results

EAGLE, Idaho, July 17, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced it will report financial results for the second quarter and six months ended June 30, 2024, on Wednesday, August 7, 2024, after the market close.

PetIQ, Inc. to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024

Freshpet

Zoetis

Chewy (NYSE: CHWY ) has recently become what some would consider to be a meme stock. On June 24, influential investor Keith Gill, also known as Roaring Kitty, disclosed the purchase of 9 million shares, valued at roughly $245 million.

3 Pet Stocks That Are Better Buys Than Chewy

PetIQ (PETQ) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Why Fast-paced Mover PetIQ (PETQ) Is a Great Choice for Value Investors

EAGLE, Idaho, June 05, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and wellness company, today announced that members of its executive management team will participate in the Oppenheimer 24th Annual Consumer Growth and E-Commerce Conference. A virtual fireside chat will be available on Tuesday, June 11, 2024 at 10:30 a.m. EDT. The live webcast and replay is accessible on the “Investors” section of the Company's website at www.PetIQ.com.

News for PetIQ Stock (PETQ)